Secondary Logo

Institutional members access full text with Ovid®

CORR® International – Asia-Pacific

Stem Cell-based Treatments in Orthopaedic Clinical Practice—Is it Ready For Primetime in the Asia-Pacific Region?

Kim, Tae Kyun, MD, PhD

Clinical Orthopaedics and Related Research®: April 2019 - Volume 477 - Issue 4 - p 695–697
doi: 10.1097/CORR.0000000000000697

T. K. Kim, Department of Orthopedic Surgery, TK Orthopedic Surgery, Seongnam, Korea

T. K. Kim MD, PhD, TK Orthopedic Surgery, 55 Dongpankyo-ro, Bundang-gu, Seongnam, Republic of Korea, Email:

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

A Note from the Editor-in-Chief: I am pleased to introduce the next installment of “CORR International – Asia-Pacific.” In this quarterly column, Professor T. K. Kim covers the issues of moment to orthopaedic surgeons and scientists practicing in the Asia-Pacific region, where nearly a quarter of CORR’s readers are located. Prof. Kim, from Seoul, South Korea, is an internationally renowned knee surgeon and one of CORR’s Deputy Editors.

One of the authors certifies that he (TKK) or a member of his immediate family, has received or may receive payments or benefits, during the study period, an amount of less than 10,000 USD from Smith & Nephew (London, UK).

The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

Received February 04, 2019

Accepted February 04, 2019

© 2019 Lippincott Williams & Wilkins LWW
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website